Drugs and the Future -  Martin Ince,  Andrew Jackson,  David J. Nutt,  Trevor W. Robbins,  Gerald V. Stimson

Drugs and the Future (eBook)

Brain Science, Addiction and Society
eBook Download: PDF
2006 | 1. Auflage
616 Seiten
Elsevier Science (Verlag)
978-0-08-046774-0 (ISBN)
Systemvoraussetzungen
80,95 inkl. MwSt
  • Download sofort lieferbar
  • Zahlungsarten anzeigen
This book presents 13 reviews collected to present the new advances in all areas of addiction research, including knowledge gained from mapping the human genome, the improved understanding of brain pathways and functions that are stimulated by addictive drugs, experimental and clinical psychology approaches to addiction and treatment, as well as both ethical considerations and social policy. The book also includes chapters on the history of addictive substances and some personal narratives of addiction. Introduced by Sir David King, Science Advisory to the UK Government and head of the Office of Science and Technology, and Nora Volkow, director of the National Institute on Drug Abuse in the USA, the book uniquely covers the full range of disciplines which can provide insight into the future of addiction, from genetics to the humanities. Written for a scientific audience, it is also applicable to non-specialists as well.

* Provides an unique overview of what we know about addiction, and how scientific knowledge can and should be applied in the societal, ethical, and political context
* Applies the state-of-the-art research in fields such as Genomics, Neuroscience, Pharmacology, Social Policy and Ethics to addiction research
* Includes a preface by Sir David King, Science Advisory to the UK Government and head of the Office of Science and Technology, and in introduction by Nora Volkow, director of the National Institute on Drug Abuse in the USA
Drugs and the Future presents 13 reviews collected to present the new advances in all areas of addiction research, including knowledge gained from mapping the human genome, the improved understanding of brain pathways and functions that are stimulated by addictive drugs, experimental and clinical psychology approaches to addiction and treatment, as well as both ethical considerations and social policy. The book also includes chapters on the history of addictive substances and some personal narratives of addiction. Introduced by Sir David King, Science Advisory to the UK Government and head of the Office of Science and Technology, and Nora Volkow, director of the National Institute on Drug Abuse in the USA, the book uniquely covers the full range of disciplines which can provide insight into the future of addiction, from genetics to the humanities. Written for a scientific audience, it is also applicable to non-specialists as well. Provides an unique overview of what we know about addiction, and how scientific knowledge can and should be applied in the societal, ethical, and political context Applies the state-of-the-art research in fields such as Genomics, Neuroscience, Pharmacology, Social Policy and Ethics to addiction research Includes a preface by Sir David King, Science Advisory to the UK Government and head of the Office of Science and Technology, and in introduction by Nora Volkow, director of the National Institute on Drug Abuse in the USA

Front cover 1
DRUGS AND THE FUTURE 4
Copyright page 5
Table of contents 6
Contributors 8
Foreword Drugs and the Future 10
Introduction 12
Acknowledgements 14
Chapter 1. Drugs Futures 2025 16
Chapter 2. Foresight 22
1 INTRODUCTION 22
2 WHAT IS FORESIGHT? 22
3 WHAT APPROACH DID WE USE TO EXPLORE THE FUTURE OF DRUG USE? 23
4 WHAT HAPPENS NEXT? 25
Chapter 3. Neuroscience of Drugs and Addiction 26
1 EXECUTIVE SUMMARY 27
2 INTRODUCTION 28
3 NEUROPSYCHOLOGY OF REINFORCEMENT LEARNING AND ADDICTION 30
4 THE NEURAL SYSTEM BASIS OF REINFORCEMENT LEARNING: RELEVANCE TO NATURAL MOTIVATION AND DRUG ADDICTION 34
5 NEUROBIOLOGY OF RELAPSE 41
6 NEUROADAPTATIONS – INTRACELLULAR CASCADES 44
7 VULNERABILITY TO ADDICTION 47
8 HARMS CAUSED BY DRUGS OF ABUSE 55
9 DRUG ADDICTION: A SOCIAL COGNITIVE NEUROSCIENCE PERSPECTIVE 57
10 THE MIND/BRAIN INTERFACE: NEUROBEHAVIOURAL ECONOMICS OF ADDICTION 60
11 FUTURE IMPLICATIONS: NEW DRUGS, THEIR IMPACT AND MANAGEMENT 66
Chapter 4. Genomics 104
1 EXECUTIVE SUMMARY 104
2 GENES IN ACTION 106
3 GENETIC ANALYSIS 112
4 CURRENT STATE OF PLAY 120
5 FUTURE DIRECTIONS IN RESEARCH 129
6 THE IMPLICATIONS OF DEFINING GENETIC INFLUENCES IN DRUG USE FOR THE INDIVIDUAL AND SOCIETY 133
7 THE BRAIN SCIENCE, ADDICTION AND DRUGS PROJECT QUESTIONS 134
8 CONCLUSIONS 135
Chapter 5. Experimental Psychology and Research into Brain Science, Addiction and Drugs 148
1 EXECUTIVE SUMMARY 148
2 INTRODUCTION 149
3 SCIENTIFIC BASIS OF DRUG ADDICTION 152
4 CURRENT PSYCHOACTIVE SUBSTANCES – EFFECTS AND HARMS 160
5 INTERVENTIONS AND MANAGEMENT 164
6 VISIONS FOR THE FUTURE – FUTURE CAPABILITIES AND APPLICATIONS 167
7 CONCLUSIONS 173
Chapter 6. Pharmacology and Treatments 184
1 EXECUTIVE SUMMARY 184
2 DEFINITIONS AND SCOPE OF REVIEW 185
3 BACKGROUND 188
4 CURRENT PSYCHOACTIVE DRUGS 191
5 DRUG TREATMENTS FOR SUBSTANCE USE DISORDERS 198
6 FUTURE PSYCHOACTIVE SUBSTANCES 201
7 FUTURE THERAPEUTICS 203
8 CONTEXT OF FUTURE TREATMENTS 209
9 PROSPECTS 210
10 APPENDIX: ACRONYMS 223
Chapter 7. Psychological Treatments of Substance Misuse and Dependence 224
1 EXECUTIVE SUMMARY 225
2 INTRODUCTION 225
3 WHERE ARE WE NOW? THE CURRENT EVIDENCE BASE ON PSYCHOLOGICAL TREATMENTS 229
4 PSYCHOLOGICAL TREATMENTS OF SUBSTANCE MISUSE AND DEPENDENCE: THE FUTURE? 239
5 WHAT WILL BE THE DRUGS OF THE FUTURE? 242
6 PSYCHOSOCIAL TREATMENTS OF THE FUTURE 244
7 PREVENTION STRATEGIES IN THE FUTURE? 248
8 CONCLUSIONS 249
Chapter 8. Cognition Enhancers 256
1 EXECUTIVE SUMMARY 257
2 DEFINITIONS AND SCOPE OF REVIEW 257
3 BACKGROUND 258
4 BASIS OF LEARNING AND MEMORY 259
5 CURRENT COGNITION ENHANCERS 262
6 COGNITION ENHANCERS IN DEVELOPMENT 277
7 FUTURE COGNITION ENHANCERS 281
8 IMPLICATIONS 283
9 CONCLUSIONS 285
Chapter 9. Neuroimaging 300
1 EXECUTIVE SUMMARY 301
2 FUNCTIONAL NEUROIMAGING IN THE STUDY OF DRUG ADDICTION: DEFINING PHARMACOLOGY AND CRAVING 301
3 FUNCTIONAL NEUROIMAGING IN THE STUDY OF DRUG ADDICTION 307
4 FUNCTIONAL NEUROIMAGING IN PRECLINICAL MODELS OF ADDICTION 312
5 MOLECULAR IMAGING AND THE ROLE OF PET 315
6 ADVANCES IN MRI/S TECHNOLOGY 317
7 TRANSCRANIAL MAGNETIC STIMULATION 321
8 FURTHER DEVELOPMENTS 323
Chapter 10. Drug Testing 330
1 EXECUTIVE SUMMARY 330
2 INTRODUCTION 331
3 TEST MATRICES 332
4 ANALYTICAL METHODS 337
5 EMERGING TECHNOLOGIES 346
6 THE FUTURE OF DRUG TESTING 349
7 CONCLUSIONS 350
Chapter 11. Social Policy and Psychoactive Substances 352
1 EXECUTIVE SUMMARY 352
2 OPTIONS FOR CONTROLLING PSYCHOACTIVE SUBSTANCES 353
3 INSTRUMENTS AND MEANS OF GOVERNANCE AND CHANGE 363
4 POLICY IMPACT STUDIES 363
5 SCENARIOS FOR THE FUTURE 366
6 AN OPPORTUNITY FOR RESEARCH – AND FOR EVIDENCE-BASED POLICIES 369
Chapter 12. Sociology and Substance Use 374
1 EXECUTIVE SUMMARY 374
2 INTRODUCTION 377
3 SOCIOLOGICAL RESEARCH IN THE SUBSTANCE USE/MISUSE FIELD 377
4 DEVELOPMENTS IN THE PREVALENCE OF SUBSTANCE USE AND MISUSE 380
5 INDIVIDUAL SOCIAL AND CULTURAL FACTORS INFLUENCING DRUG USE 389
6 TREATMENT 392
7 CONCLUSIONS 395
Chapter 13. Economics of Addiction and Drugs 404
1 EXECUTIVE SUMMARY 404
2 INTRODUCTION 406
3 THE ROLE OF ECONOMIC THEORY 406
4 THE EMPIRICAL PICTURE 412
5 COST-EFFECTIVE MANAGEMENT OF SUBSTANCE MISUSE 417
6 PATTERNS OF DRUG ADOPTION 419
Chapter 14. Problem Gambling and Other Behavioural Addictions 432
1 EXECUTIVE SUMMARY 432
2 INTRODUCTION TO THE CONCEPT OF BEHAVIOURAL ADDICTION 434
3 GAMBLING ADDICTION 436
4 ACCOUNTING FOR THE DEVELOPMENT OF A BEHAVIOURAL ADDICTION SUCH AS GAMBLING 439
5 AVAILABILITY OF TREATMENTS FOR BEHAVIOURAL ADDICTIONS 445
6 CONCLUSION: CURRENT SCIENCE CAPABILITY AND DEVELOPMENTS IN THE NEXT 10 YEARS 447
Chapter 15. Ethical Aspects of Developments in Neuroscience and Drug Addiction 454
1 EXECUTIVE SUMMARY 454
2 ETHICAL ISSUES OF POTENTIAL CLINICAL APPLICATIONS: THE NEXT 20 YEARS? 455
3 VACCINATIONS AND DRUG MISUSE 456
4 GENETICS AND INDIVIDUALISED INFORMATION 463
5 NEURAL IMAGING 468
6 PERFORMANCE, COGNITIVE ENHANCEMENTS AND DRUG ADDICTION 469
7 CONCLUSIONS 472
Chapter 16. History and the Future of Psychoactive Substances 482
1 EXECUTIVE SUMMARY 482
2 INTRODUCTION 483
3 WHAT WILL BE THE PSYCHOACTIVE SUBSTANCES OF THE FUTURE? 483
4 WHAT ARE THE EFFECTS OF USING PSYCHOACTIVE SUBSTANCES? 490
5 WHAT MECHANISMS DO WE HAVE TO MANAGE THE USE OF PSYCHOACTIVE SUBSTANCES? 492
6 CONCLUSIONS 496
Chapter 17. Life Histories and Narratives of Addiction 500
1 EXECUTIVE SUMMARY 500
2 INTRODUCTION 502
3 NARRATIVE THEORY 503
4 CONCEPT OF ADDICTION 505
5 ADDICTION – ITS LITERARY DEPICTION IN THE NINETEENTH CENTURY 506
6 ILLNESS NARRATIVES 507
7 ADDICTIONS OF THE PAST, PRESENT AND FUTURE 512
8 WHAT KINDS OF INTERVENTION MIGHT BE SUCCESSFUL IN PREVENTING ADDICTION? 516
9 CONCLUSIONS 516
10 APPENDIX: SUMMARIES OF POST-1950S ADDICTION NARRATIVES CONSIDERED 519
Chapter 18. Drugs Futures 2025? Perspective of the Pharmaceutical Industry 522
1 EXECUTIVE SUMMARY 522
2 INTRODUCTION 524
3 SURVEY RESULTS 529
4 APPENDIX: SURVEY MATERIAL 543
Chapter 19. The Scenarios 550
1 INTRODUCTION 551
2 SCENARIO PLANNING 551
3 OVERVIEW OF THE SCENARIOS 552
4 HIGH PERFORMANCE 555
5 NEIGHBOURHOOD WATCH 561
6 DISPENSE WITH CARE 566
7 TREATED POSITIVELY 570
8 WORKING WITH THE SCENARIOS 575
9 APPENDIX: METHODOLOGY 577
Author Index 582
Subject Index 612

PDFPDF (Adobe DRM)
Größe: 7,8 MB

Kopierschutz: Adobe-DRM
Adobe-DRM ist ein Kopierschutz, der das eBook vor Mißbrauch schützen soll. Dabei wird das eBook bereits beim Download auf Ihre persönliche Adobe-ID autorisiert. Lesen können Sie das eBook dann nur auf den Geräten, welche ebenfalls auf Ihre Adobe-ID registriert sind.
Details zum Adobe-DRM

Dateiformat: PDF (Portable Document Format)
Mit einem festen Seiten­layout eignet sich die PDF besonders für Fach­bücher mit Spalten, Tabellen und Abbild­ungen. Eine PDF kann auf fast allen Geräten ange­zeigt werden, ist aber für kleine Displays (Smart­phone, eReader) nur einge­schränkt geeignet.

Systemvoraussetzungen:
PC/Mac: Mit einem PC oder Mac können Sie dieses eBook lesen. Sie benötigen eine Adobe-ID und die Software Adobe Digital Editions (kostenlos). Von der Benutzung der OverDrive Media Console raten wir Ihnen ab. Erfahrungsgemäß treten hier gehäuft Probleme mit dem Adobe DRM auf.
eReader: Dieses eBook kann mit (fast) allen eBook-Readern gelesen werden. Mit dem amazon-Kindle ist es aber nicht kompatibel.
Smartphone/Tablet: Egal ob Apple oder Android, dieses eBook können Sie lesen. Sie benötigen eine Adobe-ID sowie eine kostenlose App.
Geräteliste und zusätzliche Hinweise

Buying eBooks from abroad
For tax law reasons we can sell eBooks just within Germany and Switzerland. Regrettably we cannot fulfill eBook-orders from other countries.

Mehr entdecken
aus dem Bereich
Therapie psychotraumatischer Belastungssyndrome

von Arne Hofmann; Maria Lehnung

eBook Download (2023)
Georg Thieme Verlag KG
78,99
Das Manual zur psychologischen Gesundheitsförderung

von Gert Kaluza

eBook Download (2023)
Springer-Verlag
29,99